Here is What Hedge Funds Think About Allscripts Healthcare Solutions Inc (MDRX)

Page 2 of 2

Due to the fact that Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) has experienced unchanged interest from the entirety of the hedge funds we track, we must take a look at a sect of fund managers that slashed their positions entirely in the third quarter. Interestingly, Jean-Marie Eveillard’s First Eagle Investment Management said goodbye to the largest stake of the “upper crust” of funds followed by Insider Monkey, worth close to $60.6 million in stock, and Israel Englander’s Millennium Management was right behind this move, as the fund dropped about $14.2 million worth of MDRX shares. These bearish behaviors are interesting, as total hedge fund interest stayed the same (this is a bearish signal in our experience).

Let’s now take a look at hedge fund activity in other stocks – not necessarily in the same industry as Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) but similarly valued. We will take a look at Lexington Realty Trust (NYSE:LXP), Lexmark International Inc (NYSE:LXK), United Natural Foods, Inc. (NASDAQ:UNFI), and The Medicines Company (NASDAQ:MDCO). This group of stocks’ market caps match that of MDRX.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
LXP 16 54051 3
LXK 25 303638 -3
UNFI 21 162679 0
MDCO 27 584714 1

As you can see these stocks had an average of 22 hedge funds with bullish positions and the average amount invested in these stocks was $276 million. That figure was $553 million in MDRX’s case. The Medicines Company (NASDAQ:MDCO) is the most popular stock in this table. On the other hand Lexington Realty Trust (NYSE:LXP) is the least popular one with only 16 bullish hedge fund positions. Compared to these stocks Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: none.

Page 2 of 2